Literature DB >> 19307986

Altered nitric oxide calcium responsiveness of aortic smooth muscle cells in spontaneously hypertensive rats depends on low expression of cyclic guanosine monophosphate-dependent protein kinase type I.

Lorenzo Di Cesare Mannelli1, Silvia Nistri, Luca Mazzetti, Daniele Bani, Robert Feil, Paola Failli.   

Abstract

OBJECTIVES: The nitric oxide/cyclic guanosine monophosphate (GMP)/cyclic GMP-dependent protein kinase type I (cGKI) pathway has been extensively investigated in the spontaneously hypertensive rat (SHR) as a possible pathogenetic factor. Therefore, we investigated the role of nitric oxide/cGKI on intracellular calcium dynamics ([Ca2+]i) of aortic smooth muscle cells isolated from control normotensive Wistar Kyoto rats (WKY) and SHR.
METHODS: Rat aortic smooth muscle cells (RASMCs) were obtained from 12 to 16-week-old WKY and SHR. [Ca2+]i dynamics were monitored by imaging analysis of fura-2-loaded RASMCs. cGKI mRNA and cGKI protein expression were evaluated by reverse transcription-PCR and western blot. Plasmids codifying for enhanced green fluorescent protein (EGFP) or cGKIalpha-EGFP were transfected on SHR RASMCs.
RESULTS: Angiotensin II similarly increased [Ca2+]i in WKY and SHR RASMCs. In WKY RASMCs, S-nitroso-N-acetyl-DL-penicillamine (SNAP, 1-100 micromol/l) reduced the decay time of angiotensin II-induced [Ca2+]i transient. On the contrary, in SHR cells, SNAP was ineffective. Dibutyryl cyclic GMP (1-100 nmol/l), a membrane-permeable cyclic GMP analogue, behaved similarly to SNAP. In naive SHR RASMCs, cGKI mRNA and cGKI protein were low or absent. After transfection of a plasmid encoding for cGKIalpha-EGFP, the [Ca2+]i dynamic of SHR-transfected cells regained sensitivity to the nitric oxide/cyclic GMP pathway.
CONCLUSION: The low expression of cGKI determines the lack of nitric oxide/cyclic GMP-dependent regulation on [Ca2+]i transient in SHR RASMCs. This alteration may contribute to the development of hypertension and explain suboptimal responses to nitroglycerin and other nitric oxide-releasing molecules in patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19307986     DOI: 10.1097/HJH.0b013e328329d18c

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  2 in total

1.  cGMP-dependent protein kinase I in vascular smooth muscle cells improves ischemic stroke outcome in mice.

Authors:  Maria Shvedova; Maxim M Litvak; Jesse D Roberts; Dai Fukumura; Tomoaki Suzuki; İkbal Şencan; Ge Li; Paula Reventun; Emmanuel S Buys; Hyung-Hwan Kim; Sava Sakadžić; Cenk Ayata; Paul L Huang; Robert Feil; Dmitriy N Atochin
Journal:  J Cereb Blood Flow Metab       Date:  2019-08-18       Impact factor: 6.200

2.  Calcimimetic R-568 vasodilatory effect on mesenteric vascular beds from normotensive (WKY) and spontaneously hypertensive (SHR) rats. Potential involvement of vascular smooth muscle cells (vSMCs).

Authors:  Natalia Di Pietro; Maria Assunta Potenza; Sara Di Silvestre; Francesco Addabbo; Nadia Di Pietrantonio; Pamela Di Tomo; Caterina Pipino; Domitilla Mandatori; Carola Palmerini; Paola Failli; Mario Bonomini; Monica Montagnani; Assunta Pandolfi
Journal:  PLoS One       Date:  2018-08-09       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.